Quality of life in children and adolescents with bipolar I depression treated with olanzapine/fluoxetine combination
Abstract Background We examined the efficacy of olanzapine/fluoxetine combination (OFC) in improving health-related quality of life (QoL) in the treatment of bipolar depression in children and adolescents. Methods Patients aged 10–17 years with bipolar I disorder, depressed episode, baseline childre...
Main Authors: | Daniel J. Walker, Melissa P. DelBello, John Landry, Deborah N. D’Souza, Holland C. Detke |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-07-01
|
Series: | Child and Adolescent Psychiatry and Mental Health |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13034-017-0170-7 |
Similar Items
-
Treatment of acute bipolar depression
by: Yu-Chih Shen
Published: (2018-01-01) -
Pharmacotherapy of adolescent depression - fluoxetine monotherapy or combined treatment?
by: Cesneková D., et al.
Published: (2017-09-01) -
Efficacy and safety of olanzapine/fluoxetine combination in the treatment of treatment-resistant depression: a meta-analysis of randomized controlled trials
by: Luan S, et al.
Published: (2017-02-01) -
Olanzapine discontinuation emergent recurrence in bipolar disorder
by: Manu Arora, et al.
Published: (2014-01-01) -
Simultaneous determination of olanzapine and fluoxetine hydrochloride in capsules by spectrophotometry, TLC-spectrodensitometry and HPLC
by: Mahmoud A. Tantawy, et al.
Published: (2013-03-01)